TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CRVO

CervoMed Inc.

Healthcare · Biotechnology

2.40$ -4.7% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement CRVO
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0%
118.1% 193.0%
-18.1% -93.0%
118.1% 193.0% 544.5%
91.2% 94.1% 261.7%
109.3% 187.2% 706.2%
-109.3% -187.2% -706.2%
0.0%
-30.4% -167.3% -673.1%
11.2%
-30.4% -167.3% -673.1%
-30.4% -167.3% -673.1%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?